Pure Global

Assessing the Right Heart Remodeling After Transcatheter Tricuspid Edge-to-edge Repair - Trial NCT06309524

Access comprehensive clinical trial information for NCT06309524 through Pure Global AI's free database. This phase not specified trial is sponsored by Istituto Auxologico Italiano and is currently Recruiting. The study focuses on Tricuspid Regurgitation. Target enrollment is 17 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
Device Trial
NCT06309524
Recruiting
Device Trial
device
Trial Details
ClinicalTrials.gov โ€ข NCT06309524
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Assessing the Right Heart Remodeling After Transcatheter Tricuspid Edge-to-edge Repair
Valutazione Del Rimodellamento Delle Camere Destre Dopo Trattamento Transcatetere Edge-to-edge Dell'Insufficienza Tricuspidale Severa

Study Focus

Tricuspid Regurgitation

Tricuspid transcatheter edge-to-edge repair

Observational

device

Sponsor & Location

Istituto Auxologico Italiano

Milan, Italy

Timeline & Enrollment

N/A

Feb 15, 2023

Jan 01, 2025

17 participants

Primary Outcome

Inverse remodeling of right heart chambers,Heart failure hospitalization,Death

Summary

In the recent years, secondary tricuspid regurgitation (STR) has gained interest due to its
 high prevalence and impact on outcomes. Transcatheter tricuspid valve replacement or repair
 represents novel and less invasive alternatives to surgery and has shown early promising
 results. Treatment options mimic surgical techniques such as leaflet approximation, direct
 annuloplasty, and heterotopic caval valve implantation, as well as not yet commercially
 available transcatheter TV replacement systems using orthotopic valve implantation. (5) Among
 leaflet approximation techniques, the Tricuspid transcatheter edge-to-edge repair (T-TEER)
 using the TriClipโ„ข (Abbott Vascular, Santa Clara, CA, USA) or leaflet approximation with the
 PASCAL systems (Edwards Lifesciences, Irvine, CA, USA) are approved in Europe for minimally
 invasive TV repair.The purposes of the present study are: i. to use 3DE and CCT to evaluate
 the effect of T-TEER on the geometry and function of the right heart chambers in patients
 with STR; ii. to identify the predictors of procedural success potentially related to
 features of both right chambers geometry and TR jet; iii. to compare the accuracy of 3DE
 assessment of the right ventricle, the right atrium, and the tricuspid annulus, with the same
 parameters obtained by CCT, in the setting of T-TEER; and iv. to assess patients' outcome.

ICD-10 Classifications

Tricuspid stenosis
Tricuspid stenosis with insufficiency
Nonrheumatic tricuspid (valve) stenosis
Tricuspid insufficiency
Nonrheumatic tricuspid (valve) stenosis with insufficiency

Data Source

ClinicalTrials.gov

NCT06309524

Device Trial